miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10.
Biomed Pharmacother. 2018 Jul;103:1312-1318
Authors: Wang X, Li J, Xu X, Zheng J, Li Q
Abstract Although the treatment strategies for neuroblastoma (NB) develop rapidly, a considerable number of patients could not benefit from chemotherapy. Here, we revealed a miR-129-MYO10 axis that regulated neuroblastoma growth and chemosensitivity.